Company Quick10K Filing
Angiosoma
10-Q 2020-06-30 Filed 2020-07-14
10-Q 2020-03-31 Filed 2020-05-05
10-Q 2019-12-31 Filed 2020-02-14
10-K 2019-09-30 Filed 2019-12-31
10-Q 2019-06-30 Filed 2019-08-02
10-Q 2019-03-31 Filed 2019-05-15
10-Q 2018-12-31 Filed 2019-02-19
10-K 2018-09-30 Filed 2019-01-03
10-Q 2018-06-30 Filed 2018-08-01
10-Q 2018-03-31 Filed 2018-05-21
10-Q 2017-12-31 Filed 2018-02-15
10-K 2017-09-30 Filed 2018-01-16
10-Q 2017-06-30 Filed 2017-08-18
10-Q 2017-03-31 Filed 2017-05-19
10-Q 2016-12-31 Filed 2017-04-10
10-K 2016-09-30 Filed 2017-03-29
10-Q 2016-06-30 Filed 2016-09-13
10-Q 2016-03-31 Filed 2016-05-23
10-Q 2015-12-31 Filed 2016-02-22
10-K 2015-09-30 Filed 2016-01-13
10-Q 2015-06-30 Filed 2015-08-17
10-Q 2015-03-31 Filed 2015-05-15
10-Q 2014-12-31 Filed 2015-02-17
10-K 2014-09-30 Filed 2015-01-14
10-Q 2014-06-30 Filed 2014-08-19
10-Q 2014-03-31 Filed 2014-05-20
10-Q 2013-12-31 Filed 2014-02-14
10-K 2013-09-30 Filed 2014-01-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-Q 2012-12-31 Filed 2013-02-14
10-K 2012-09-30 Filed 2013-01-15
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-21
10-Q 2011-12-31 Filed 2012-02-14
10-K 2011-09-30 Filed 2011-12-29
10-Q 2011-06-30 Filed 2011-08-11
10-Q 2011-03-31 Filed 2011-05-04
10-Q 2010-12-31 Filed 2011-03-10
8-K 2020-08-23 Enter Agreement, Exhibits
8-K 2020-08-12 Officers
8-K 2019-10-28
8-K 2019-10-25
8-K 2019-10-16
8-K 2019-08-16
8-K 2018-12-13
8-K 2018-06-14
8-K 2018-05-14
8-K 2018-02-23
8-K 2017-09-30

Angiosoma Financials

SOAN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Natcore Technology (NXT)
OncBioMune (OBMP) 0 0.0 -1,707% 413 14,090 0 0 -7,048 -5,617 -136
Cantabio Pharmaceuticals (CTBO) 0 0.9 -474% 326 2,215 0 0 -1,543 -331 -283
Amplitude Healthcare (AMHCU)
GIFA (FRFS) 0 63% -0.9 43% 80 362 98 62 34 34 -30
Highcom Global Security (HCGS) 0 41% -0.8 1% 9,334 1,222 4,918 2,033 57 172 -131
Nutra Pharma (NPHC) 0 71% -0.2 -2,939% 252 5,614 106 75 -7,398 -6,591 1,498
Premier Biomedical (BIEI) 0 58% -0.3 -183% 186 2,304 13 8 -340 -238 75
Electromedical Technologies (ELCQ)
DigitalTown (DGTW) 0 12,618% 0.0 -16,557% 34 2,761 -2 -220 -5,706 -5,268 -34
Life Clips (LCLP) 0 135% -0.7 -21,823% 16 9,270 -86 -116 -3,494 -3,182 2,355
Anchiano Therapeutics (ANCN)
X Rail Entertainment (XREE) 0 -0.1 -1,441,401% 0 3,429 0 0 -5,261 -5,732 345
Bulova Technologies (BTGI)
Angiosoma (SOAN) 0 64% -0.2 -475% 142 828 0 0 -675 -315 66
GH Capital (GHHC) 0 66% -0.0 -2,680% 89 331 211 139 -2,374 -2,374 59
Galileo Acquisition (GLEO)
Sunshine Biopharma (SBFM) 0 30% 0.1 -864% 146 889 130 38 -1,264 -1,160 -82
True Drinks Holdings (TRUU) 0 57% 1.7 -26% 9,780 7,642 12,437 7,052 -2,515 -2,482 -4,166
Triton Emission Solutions (DSOX) 0 0.0 -10,306% 20 18,837 0 0 -2,068 -831 -1

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312013-06-302014-03-312014-12-312015-12-312016-09-302016-12-312017-03-312017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash48221572049135608146567112925484105100
Accounts Receivable22166
Inventory4440404040
PP&E111111
Assets48221263570412473303171522257888131125110139159142
Accounts Payable158268
Long-Term Debt83893587187169886969194162167209166
Liabilities263279444493566603377860894995649830874901995955983887828
Stockholders' Equity23-10-78-18178-154-130-74-843-879-973-624-752-786-769-871-845-843-728-685
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312013-06-302014-03-312014-12-312015-12-312016-09-302016-12-312017-03-312017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue035119000000000
Cost of Revenue00000
Gross Profit00000
R&D
SG&A153969103125152104119372371201294270130715462
Tax000000000000000
Net Income-17-32-69-103-178-182-226-208-3,294-317-195-465-40-91-328-190-1-156
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312013-06-302014-03-312014-12-312015-12-312016-09-302016-12-312017-03-312017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-29-63-92-69-9060-23-15-14-34-54-73-70-53-64
Cash Investing0-206-0-060000
Cash Financing3423547190-6018226535101351007460